Guo's Aortic Arch Reconstruction: The First in Man Study of WeFlow-Arch Modular Embedded Branch Stent Graft System

Aortic Arch; Aneurysm, Dissecting Clinical Trial

Official title:
Guo's Aortic Arch Reconstruction: The First in Man Study of WeFlow-Arch Modular Embedded Branch Stent Graft System

Status Completed

Clinical Trial Summary

This study is the first in man study of WeFlow-Arch Module Embedded Aorta Arch Stent Graft System

Clinical Trial Description

The WeFlow-Arch Moduler Embedded Aorta Arch Stent Graft System first in man study is a prospective, single center, single arm trial, which will enroll a total of 20 patients. The goal of this study is to evaluate the safety and efficacy of WeFlow-Arch Moduler Embedded Aorta Arch Stent Graft System in the treatment of patients with lesions of the aortic arch. ;

Study Design

Related Conditions & MeSH terms

Aneurysm
Aortic Arch; Aneurysm, Dissecting
Aortic Dissection

Clinical Trial Details

NCT number	NCT04764370
Study type	Interventional
Source	Hangzhou Endonom Medtech Co., Ltd.
Contact
Status	Completed
Phase	N/A
Start date	February 28, 2019
Completion date	October 22, 2022

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT00583817` - Endovascular Treatment of Thoracic Aortic Disease	N/A
Active, not recruiting	`NCT05421130` - Clinical Investigation of Clinical Safety and Performance of the SP-GRIPFLOW, Selective Cerebral Perfusion Catheter When Used for Cerebral Perfusion During Aortic Arch Repair	N/A
Active, not recruiting	`NCT03735472` - Study of the Thoraflex™ Hybrid Device for the Treatment of Aneurysm/Dissection of the Descending Thoracic Aorta